{"pageContent": "Purpose: To evaluate whether supplemental external beam radiotherapy (EBRT) is essential to maximize Pd-103 brachytherapy outcomes in patients with unfavorable intermediate-risk (IR) disease.", "metaData": {"source": "Survival disparities between M\u0101ori and non-M\u0101ori men with prostate cancer in New Zealand\nhttps://pubmed.ncbi.nlm.nih.gov/25124231/"}}